Skip to content
P-477 Pre-exposure prophylaxis for COVID-19 with tixagevimab/cilgavimab (evusheld) in patients with multiple myeloma in the omicron SARS-COV-2 era — Ioannis Ntanasis‐Stathopoulos (2023) | RDL Network